SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-096553
Filing Date
2023-08-29
Accepted
2023-08-29 16:05:41
Documents
12
Period of Report
2023-08-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2325056d1_8k.htm   iXBRL 8-K 29028
  Complete submission text file 0001104659-23-096553.txt   202416

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zyne-20230825.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyne-20230825_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyne-20230825_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2325056d1_8k_htm.xml XML 3345
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37526 | Film No.: 231221949
SIC: 2834 Pharmaceutical Preparations